You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
A股異動 | 華東醫藥創逾5個月新高 子公司中美華東擬收購破產重整後的華昌高科100%股權
格隆匯 12-29 11:12
格隆匯12月29日丨華東醫藥(000963.SZ)漲約3%,報39.8元創逾5個月新高,總市值696億元。華東醫藥公吿稱,全資子公司中美華東參與華昌高科破產重整,成為其重整投資人。中美華東與管理人簽署了附條件生效的《重整投資協議》,華昌高科將在破產重整後由中美華東收購其100%股權,原股東權益將調整為零,中美華東將以增資形式投入1.08億元,用於支付和清償華昌高科重整計劃涉及的破產費用、共益債務及破產債權。華東醫藥表示,華昌高科將成為其工業微生物領域全新的產業化平台。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account